+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Excipient Market - Global Forecast 2026-2032- Product Image
Pharmaceutical Excipient Market - Global Forecast 2026-2032- Product Image
Sale

Pharmaceutical Excipient Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968715
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Excipient Market is projected to reach USD 11.85 Billion in 2026. It is expected to continue growing at a CAGR of 5.34%, reaching USD 16.36 Billion by 2032.

Pharmaceutical excipients are no longer viewed as passive fillers; they are critical formulation components that influence stability, bioavailability, manufacturability, dose uniformity, patient acceptability, and product lifecycle performance. Their role spans binders, fillers, coatings, disintegrants, preservatives, solubilizers, lubricants, emulsifiers, sweeteners, surfactants, and functional polymers used across tablets, capsules, injectables, biologics, topical products, inhalation products, and advanced drug delivery systems.

Market momentum is supported by the steady expansion of generic medicines, complex oral solid dosage forms, biologics, controlled-release formulations, and patient-centric therapies. Regulatory expectations from agencies and pharmacopeias continue to emphasize excipient quality, traceability, safety qualification, impurity control, and consistent functionality, making supplier reliability and documentation depth central to competitive positioning in pharmaceutical formulation and drug manufacturing.

Transformative Shifts in the Pharmaceutical Excipient Landscape

The pharmaceutical excipient landscape is being reshaped by quality-by-design, continuous manufacturing, co-processed excipients, and multifunctional ingredients that simplify formulation development while improving process robustness. Manufacturers are prioritizing excipients that enhance solubility, compressibility, flowability, taste masking, moisture protection, and modified-release performance, particularly for poorly soluble active pharmaceutical ingredients.

Supply chain resilience has become a board-level concern following pandemic-era disruptions, geopolitical risk, and increased scrutiny of impurities, including elemental impurities and nitrosamine-related risks. At the same time, sustainability pressures are accelerating interest in responsibly sourced excipients, lower-solvent manufacturing routes, renewable raw materials, and lifecycle documentation that supports environmental, social, and governance reporting.

Cumulative Impact of Artificial Intelligence in Excipient Development

Artificial intelligence is beginning to compress formulation development timelines by enabling predictive excipient selection, digital design of experiments, stability modeling, and process-parameter optimization. AI tools can analyze historical formulation data, pharmacopeial constraints, material attributes, compatibility profiles, and manufacturing outcomes to identify excipient combinations with higher probability of technical success.

The cumulative impact is strongest where companies combine AI with high-quality experimental data, laboratory automation, real-time analytics, and validated analytical methods. In regulated environments, adoption depends on data integrity, model transparency, auditability, cybersecurity, and alignment with good manufacturing practice expectations. AI is therefore becoming a decision-support layer rather than a replacement for scientific, regulatory, and quality expertise.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a major growth engine for pharmaceutical excipients, led by China and India’s large generic drug manufacturing base, Japan’s high-quality formulation ecosystem, South Korea’s biologics capacity, and Australia’s regulated healthcare market. Demand is reinforced by expanding domestic pharmaceutical production, cost-efficient manufacturing, growing contract development and manufacturing activity, and rising consumption of finished dosage forms across oral solid, injectable, and specialty drug categories.

North America remains a premium innovation and compliance market, with the United States driving demand for high-performance excipients, complex generics, biologics, novel delivery platforms, and documentation-rich supplier qualification. Latin America is led by Brazil and Mexico, where generics, branded generics, and local production support steady use of established excipient categories. Europe is defined by strong pharmacopeial standards, mature pharmaceutical manufacturing, advanced specialty chemicals capability, and sustainability-focused procurement. The Middle East, particularly GCC markets, is investing in healthcare localization and local pharmaceutical capacity, while Africa’s demand is tied to access-focused generics, essential medicines, public health programs, and donor-supported healthcare procurement.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are benefiting from expanding pharmaceutical manufacturing, regional harmonization efforts, and growing demand for affordable generics, creating opportunities for suppliers that can provide consistent documentation, pharmacopeial compliance, and cost-effective excipient grades. GCC countries are advancing healthcare localization strategies and medicine security initiatives, encouraging regional pharmaceutical production and reliable sourcing of compliant excipients for essential and specialty therapies.

The European Union remains a benchmark for excipient quality expectations through strong regulatory alignment, pharmacopeial discipline, pharmacovigilance-linked quality systems, and sustainability requirements. BRICS economies combine large populations, domestic drug manufacturing, active pharmaceutical ingredient capacity, and expanding healthcare access, making them central to volume-driven demand for pharmaceutical excipients. G7 markets continue to lead in innovation, regulatory rigor, injectable and biologics-related applications, and high-value excipient use, while NATO-aligned supply chain planning increasingly emphasizes secure sourcing for essential medicines, critical healthcare products, and resilient pharmaceutical manufacturing networks.

Key Country Insights Across Major Pharmaceutical Excipient Markets

The United States anchors global excipient innovation through advanced formulation science, complex generics, biologics, high-value drug delivery systems, and strong FDA oversight, while Canada benefits from regulated pharmaceutical imports, local production, and established quality systems. Mexico is gaining relevance as a nearshoring and manufacturing hub supported by proximity to the U.S. healthcare supply chain, and Brazil remains Latin America’s largest pharmaceutical market with consistent demand for oral solid dosage, topical, and injectable excipients.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature pharmaceutical manufacturing, strong regulatory systems, and demand for high-functionality excipients; Germany and France are especially important for specialty chemicals, process engineering, and formulation expertise. Russia maintains demand through domestic medicine programs despite supply constraints and changing sourcing patterns. In Asia-Pacific, China and India dominate volume growth due to scale in generics, active pharmaceutical ingredient production, and contract manufacturing, Japan prioritizes premium quality and advanced dosage forms, South Korea is linked to biologics and high-tech manufacturing, and Australia supports demand through a regulated, import-reliant healthcare system with strict quality expectations.

Actionable Recommendations for Pharmaceutical Excipient Industry Leaders

Industry leaders should strengthen supplier qualification, dual sourcing, regional inventory strategies, and risk-based sourcing models for critical excipients to reduce exposure to logistics disruptions, quality variability, and geopolitical risk. Building closer technical collaboration between excipient suppliers, formulation teams, quality units, and contract development and manufacturing organizations can accelerate product development and improve first-time-right outcomes.

Companies should invest in excipient characterization, functionality-related specifications, impurity control, digital quality systems, and regulatory documentation readiness. High-priority opportunities include co-processed excipients, solubility-enhancing platforms, modified-release polymers, injectable-grade excipients, bioavailability-enhancing systems, and excipients designed for biologics, pediatric formulations, geriatric medicines, orally disintegrating tablets, and continuous manufacturing.

Research Methodology for Pharmaceutical Excipient Analysis

The research methodology combines secondary research from regulatory agencies, pharmacopeias, industry associations, scientific literature, public health databases, trade references, product catalogs, and publicly available regulatory and quality documentation. Key sources include FDA guidance and databases, European Medicines Agency materials, United States Pharmacopeia-National Formulary standards, European Pharmacopoeia references, World Health Organization materials, and IPEC guidance on excipient quality, safety, and qualification.

Findings are validated through triangulation across demand indicators, manufacturing footprint, dosage-form trends, regulatory developments, supply chain shifts, and supplier activity. Primary insights are derived from interviews and discussions with formulation scientists, procurement executives, quality leaders, distributors, regulatory specialists, and excipient manufacturers, with interpretation refined through segmentation by chemistry, functionality, dosage form, route of administration, application area, and geography.

Conclusion: Pharmaceutical Excipients as Strategic Enablers of Drug Performance

The pharmaceutical excipient market is entering a more strategic phase, driven by complex formulations, stricter quality expectations, resilient supply chain planning, biologics expansion, and the shift toward patient-centric drug delivery. Excipients that deliver measurable functionality, documentation strength, impurity control, and regulatory confidence are becoming essential to pharmaceutical competitiveness.

Future industry advantage will favor suppliers and drug developers that combine scientific credibility, regional supply resilience, digital formulation capabilities, and sustainability-aligned operations. As medicines become more complex and manufacturing models evolve, pharmaceutical excipients will remain central to product performance, patient outcomes, manufacturability, and lifecycle value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Excipient Market, by Type
7.1. Introduction
7.2. Inorganic
7.2.1. Calcium Carbonate
7.2.2. Calcium Phosphate
7.2.3. Calcium Sulfate
7.2.4. Halites
7.2.5. Metal Oxides
7.3. Organic
7.3.1. Carbohydrates
7.3.1.1. Cellulose
7.3.1.2. Starch
7.3.1.3. Sugars
7.3.2. Oleochemicals
7.3.2.1. Fatty Alcohols
7.3.2.2. Glycerin
7.3.2.3. Mineral Stearates
7.3.3. Petrochemicals
7.3.3.1. Acrylic Polymers
7.3.3.2. Glycols
7.3.3.3. Mineral Hydrocarbons
7.3.3.4. Povidones
7.3.4. Proteins
8. Pharmaceutical Excipient Market, by Formulation
8.1. Introduction
8.2. Oral Formulations
8.2.1. Hard Gelatin Capsules
8.2.2. Liquid Formulations
8.2.3. Soft Gelatin Capsules
8.2.4. Tablets
8.3. Parenteral Formulations
8.4. Topical Formulations
9. Pharmaceutical Excipient Market, by Function
9.1. Introduction
9.2. Binders
9.3. Coating Agents
9.4. Colorants
9.5. Disintegrants
9.6. Emulsifying Agents
9.7. Fillers & Diluents
9.8. Flavoring Agents & Sweeteners
9.9. Lubricants & Glidants
9.10. Preservatives
9.11. Suspending & Viscosity Agents
10. Pharmaceutical Excipient Market, by End-User
10.1. Introduction
10.2. Biopharmaceutical Companies
10.3. Contract Manufacturing Organizations
10.4. Pharmaceutical Companies
10.5. Research Laboratories
11. Pharmaceutical Excipient Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Pharmaceutical Excipient Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Pharmaceutical Excipient Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Pharmaceutical Excipient Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ABITEC Corporation
16.2. Asahi Kasei Corporation
16.3. Ashland Inc.
16.4. BASF SE
16.5. Chemische Fabrik Budenheim KG
16.6. Clariant AG
16.7. Colorcon Inc.
16.8. Croda International Plc
16.9. DFE Pharma GmbH & Co. KG
16.10. DuPont de Nemours, Inc.
16.11. Evonik Industries AG
16.12. Fuji Chemical Industries Co., Ltd.
16.13. Gattefossé SAS
16.14. Innophos Holdings, Inc.
16.15. JRS Pharma GmbH & Co. KG
16.16. MEGGLE GmbH & Co. KG
16.17. Merck KGaA
16.18. NOF Corporation
16.19. Omya International AG
16.20. Peter Greven GmbH & Co. KG
16.21. Roquette Frères SA
16.22. Shin-Etsu Chemical Co., Ltd.
16.23. Sigachi Industries Ltd.
16.24. SPI Pharma, Inc.
16.25. The Lubrizol Corporation
16.26. Wacker Chemie AG
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INORGANIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INORGANIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INORGANIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CALCIUM CARBONATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CALCIUM CARBONATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CALCIUM CARBONATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CALCIUM SULFATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CALCIUM SULFATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CALCIUM SULFATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HALITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HALITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HALITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL METAL OXIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL METAL OXIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL METAL OXIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ORGANIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ORGANIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ORGANIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CARBOHYDRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CARBOHYDRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CARBOHYDRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CELLULOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CELLULOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CELLULOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL STARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL STARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL STARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SUGARS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SUGARS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SUGARS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL OLEOCHEMICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL OLEOCHEMICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL OLEOCHEMICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL FATTY ALCOHOLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL FATTY ALCOHOLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL FATTY ALCOHOLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL GLYCERIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL GLYCERIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL GLYCERIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MINERAL STEARATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MINERAL STEARATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MINERAL STEARATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PETROCHEMICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PETROCHEMICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PETROCHEMICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ACRYLIC POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ACRYLIC POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ACRYLIC POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL GLYCOLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GLYCOLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL GLYCOLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MINERAL HYDROCARBONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MINERAL HYDROCARBONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MINERAL HYDROCARBONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL POVIDONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL POVIDONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL POVIDONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PROTEINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PROTEINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PROTEINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ORAL FORMULATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ORAL FORMULATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ORAL FORMULATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HARD GELATIN CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HARD GELATIN CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HARD GELATIN CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL LIQUID FORMULATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL LIQUID FORMULATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL LIQUID FORMULATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SOFT GELATIN CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SOFT GELATIN CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SOFT GELATIN CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL TABLETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PARENTERAL FORMULATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PARENTERAL FORMULATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PARENTERAL FORMULATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TOPICAL FORMULATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TOPICAL FORMULATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BINDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL BINDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BINDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL COATING AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL COATING AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL COATING AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL COLORANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL COLORANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL COLORANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DISINTEGRANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DISINTEGRANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DISINTEGRANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL EMULSIFYING AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL EMULSIFYING AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL EMULSIFYING AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL FILLERS & DILUENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL FILLERS & DILUENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL FILLERS & DILUENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL FLAVORING AGENTS & SWEETENERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL FLAVORING AGENTS & SWEETENERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL FLAVORING AGENTS & SWEETENERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL LUBRICANTS & GLIDANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL LUBRICANTS & GLIDANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL LUBRICANTS & GLIDANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PRESERVATIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PRESERVATIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PRESERVATIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SUSPENDING & VISCOSITY AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SUSPENDING & VISCOSITY AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SUSPENDING & VISCOSITY AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 177. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 179. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 180. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 181. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 182. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 183. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 184. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 185. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 186. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 187. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 188. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 201. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 202. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 203. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 204. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 205. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 206. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 207. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 208. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 209. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 210. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 211. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 212. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 216. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 217. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 218. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 219. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 220. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 221. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 222. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 223. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 224. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 225. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 228. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 229. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 230. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 231. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 232. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 233. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 234. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 235. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 236. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 237. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 252. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 253. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 254. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 255. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 256. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 257. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 258. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 259. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 260. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 261. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 262. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 264. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 265. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 266. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 267. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 268. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 269. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 270. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 271. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 272. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 273. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 274. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 275. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 276. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 277. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 278. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 279. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 280. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 281. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 282. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 283. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 284. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 285. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 299. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 301. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 302. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 303. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 304. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 305. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 306. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 307. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 308. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 309. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 310. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 311. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 313. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 314. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 315. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 316. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 317. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 318. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 319. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 320. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 321. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 322. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 345. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 346. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 347. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 349. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2017-2032 (USD MILLION)
TABLE 350. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2017-2032 (USD MILLION)
TABLE 351. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2017-2032 (USD MILLION)
TABLE 352. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2017-2032 (USD MILLION)
TABLE 353. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2017-2032 (USD MILLION)
TABLE 354. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 355. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2017-2032 (USD MILLION)
TABLE 356. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2017-2032 (USD MILLION)
TABLE 357. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 358. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 359. FRANCE PHARMACEUTICAL EXCIPIENT MARKET

Companies Mentioned

  • ABITEC Corporation
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • Chemische Fabrik Budenheim KG
  • Clariant AG
  • Colorcon Inc.
  • Croda International Plc
  • DFE Pharma GmbH & Co. KG
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • Gattefossé SAS
  • Innophos Holdings, Inc.
  • JRS Pharma GmbH & Co. KG
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • Roquette Frères SA
  • Shin-Etsu Chemical Co., Ltd.
  • Sigachi Industries Ltd.
  • SPI Pharma, Inc.
  • The Lubrizol Corporation
  • Wacker Chemie AG

Table Information

Report AttributeDetails
No. of Pages196
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.85 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.36 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032 - Product Image

Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Nutraceutical Excipients Market - Global Forecast 2026-2032 - Product Image

Nutraceutical Excipients Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Pharmaceutical Excipients - Global Strategic Business Report - Product Image

Pharmaceutical Excipients - Global Strategic Business Report

  • Report
  • 223 Pages
  • Global
From
Sustained Release Excipients - Global Strategic Business Report - Product Image

Sustained Release Excipients - Global Strategic Business Report

  • Report
  • 136 Pages
  • Global
From
Pharmaceutical Excipients Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Pharmaceutical Excipients Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 350 Pages
  • Global
From

About the Market

The Drug Excipient market is an important part of the Pharmaceutical industry. Drug Excipients are inactive ingredients used in the production of drugs and medications. They are used to bind, fill, dissolve, stabilize, and protect the active ingredients in a drug. Excipients are also used to improve the taste, texture, and appearance of a drug. Excipients are essential components of any drug formulation, as they can affect the safety, efficacy, and stability of the drug. The Drug Excipient market is highly competitive, with many companies offering a wide range of products. Companies in the market include BASF, Roquette, Ashland, Colorcon, Evonik, and Dow. These companies provide a variety of excipients, including fillers, binders, lubricants, disintegrants, glidants, and stabilizers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.